SEC Form 4 · accession 0001358403-15-000078
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M. Spencer
Officer — Chief Scientific Officer
Period of report
Sep 21, 2015
Accepted (ET)
Sep 23, 2015 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 21, 2015 | M | 5,000 | $2.55 | A | 183,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.55 | Sep 21, 2015 | M | 5,000 | D | — | Nov 27, 2021 | Common Stock | 5,000 | 122,058 | D |
Explanation of responses
- F1The shares subject to the stock option vest and become exercisable in 48 monthly installments.